Geoffrey W. Smith is the Founder and Managing Partner of Digitalis Ventures, a venture capital firm that partners with entrepreneurs, inventors, and scientists across all stages of venture investing to back technology-driven solutions to complex problems in health. He currently represents Digitalis as a Director of GRO Biosciences and Terray Therapeutics.

He is also a Co-Founder and General Partner of Ascent Biomedical Ventures, a New York City-based venture capital firm focused on early-stage life sciences investments. Geoff currently represents Ascent on the Board of Directors of Azevan Pharmaceuticals, BlinkBio, and Orchestra Biomedical.

Geoff serves as a Trustee of The Jackson Laboratory. He also serves as the Chair of the Bard Early College Board of Governors. Previously, he was the founding Director of the Mount Sinai Institute of Technology and a Professor in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai.

Geoff received a B.A. (with honors) from Williams College and a J.D. from the University of Pennsylvania Law School.